Ingevity Corporation (NYSE: NGVT) announced its financial results for the third quarter of 2025, revealing a stable performance despite ongoing challenges in certain segments. The results reflect a strategic focus on portfolio optimization, highlighted by the planned divestiture of its Industrial Specialties product line and crude tall oil refinery, expected to close in early 2026.

1. Financial Performance Overview

In the third quarter, Ingevity recorded net sales of $333.1 million, remaining flat compared to the prior year. This stagnation was attributed to a mixture of growth in the Performance Chemicals segment's Road Technologies product line and Performance Materials segment, counterbalanced by a decline in the Advanced Polymer Technologies (APT) segment.

Net income from continuing operations was reported at $40.8 million, translating to diluted earnings per share (EPS) of $1.10. Adjusted earnings from continuing operations, which account for indirect costs related to the divestiture, were $48.3 million, maintaining the prior year's level, but diluted adjusted EPS saw a slight decline of 2% to $1.31.

Segment Highlights

Performance Materials:

Sales increased by 3% to $155.0 million, largely due to volume growth linked to improved global auto production.

Segment EBITDA fell by 1% to $79.9 million, with margins at 51.5%, impacted by higher variable compensation and adverse foreign exchange effects.

Advanced Polymer Technologies:

This segment faced a notable sales decline of $10.6 million, bringing revenue to $38.2 million. The downturn was driven by ongoing indirect tariff impacts, weak industrial demand, and heightened competition in China.

Segment EBITDA slightly increased by 1% to $9.9 million, while margins improved by 580 basis points to 25.9% due to lower raw material costs and operational efficiencies.

Performance Chemicals:

Performance Chemicals sales rose nearly 5% to $139.9 million, buoyed by record pavement sales in North America.

Segment EBITDA grew by 2% to $24.8 million, although EBITDA margins decreased by 40 basis points to 17.7%, primarily due to competitive pricing pressures in road markings.

2. Cash Flow and Financial Position

Ingevity generated $129.7 million in operating cash flow, with strong free cash flow of $117.8 million, indicating improved profitability. The company utilized this cash flow to repurchase $25 million of its shares, enhancing its net leverage to 2.7x. Approximately $328 million remains under the company's share repurchase authorization.

3. Revised Full-Year Guidance

In light of the current market conditions, Ingevity has revised its full-year 2025 guidance, projecting total net sales between $1.25 billion and $1.35 billion, and adjusted EBITDA between $390 million and $405 million. This revision reflects specific challenges within the Advanced Polymer Technologies segment, particularly concerning competitive pressures and persistent indirect tariff effects that have delayed anticipated recovery in industrial demand.

4. Executive Commentary

David Li, president and CEO of Ingevity, expressed optimism regarding the company's strategic direction, stating, "We are excited to have executed the initial step in our portfolio optimization with the announced sale of Industrial Specialties and the North Charleston refinery. Our strong quarterly results highlight the resilience of Performance Materials in a dynamic tariff environment, the successful execution of our repositioning actions, and record pavement sales in North America."

5. Looking Ahead

Ingevity will host a live webcast on November 6, 2025, to further discuss its third-quarter fiscal results, offering investors deeper insights into its ongoing strategies and future outlook.

As Ingevity navigates these strategic changes, stakeholders will be keenly observing how the company adapts to market challenges while capitalizing on opportunities for growth in its core segments. The upcoming months will be pivotal as Ingevity continues to optimize its portfolio and reinforce its market position.

Original press release